# A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

> clinical trial · VERIFIED · 2026-06-23

Status: RECRUITING · Sponsor: Novartis Pharmaceuticals · Condition: Generalized Myasthenia Gravis

- Company: Novartis Pharmaceuticals
- Sector: neurology
- Primary source: https://clinicaltrials.gov/study/NCT06517758

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.